Published in N Engl J Med on June 26, 2014
Atrial Fibrillation in Cryptogenic Stroke and TIA (NOR-FIB) | NCT02937077
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. Eur Heart J (2015) 1.86
Heart-rhythm monitoring for evaluation of cryptogenic stroke. N Engl J Med (2014) 1.46
Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology (2015) 1.42
Cryptogenic stroke and atrial fibrillation. N Engl J Med (2014) 1.42
National Trends in Ambulatory Oral Anticoagulant Use. Am J Med (2015) 1.41
Cryptogenic stroke and atrial fibrillation. N Engl J Med (2014) 1.41
Ablation of atrial fibrillation. Trends Cardiovasc Med (2014) 1.41
Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram. Int J Cardiol (2015) 1.39
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. Heart Rhythm (2014) 1.25
Cryptogenic stroke: A diagnostic challenge. Neurol Clin Pract (2014) 1.05
Electrocardiographic patch devices and contemporary wireless cardiac monitoring. Front Physiol (2015) 0.98
Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke (2015) 0.90
Controversies in cardioembolic stroke. Curr Treat Options Cardiovasc Med (2015) 0.90
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol (2016) 0.89
Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol (2015) 0.87
Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model. Stroke (2016) 0.87
Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol (2015) 0.87
Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study. Clin J Am Soc Nephrol (2016) 0.84
Cryptogenic stroke and atrial fibrillation. N Engl J Med (2014) 0.82
Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF. Neurology (2015) 0.82
Optimizing Atrial Fibrillation Management: From ICU and Beyond. Chest (2015) 0.82
Anticoagulation and population risk of stroke and death in incident atrial fibrillation: a population-based cohort study. CMAJ Open (2016) 0.81
Associations between Cardioembolic Stroke and Obstructive Sleep Apnea. Sleep (2015) 0.81
Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly. Circulation (2015) 0.81
How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices. J Stroke (2016) 0.81
Left Atrial Appendage Function and Stroke Risk. Stroke (2015) 0.80
Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis. BMJ Open (2016) 0.80
Almanac 2015: atrial fibrillation research in Heart. Heart (2016) 0.80
Subclinical Atrial Tachyarrhythmias:Implantable Devices and Remote Monitoring. J Atr Fibrillation (2015) 0.79
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. Circ Heart Fail (2015) 0.79
Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA. Front Neurol (2015) 0.79
Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag (2015) 0.79
Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study. Stroke (2015) 0.79
Mobile technology and the digitization of healthcare. Eur Heart J (2016) 0.79
Characteristics of cryptogenic stroke in cancer patients. Ann Clin Transl Neurol (2016) 0.79
Assessment of atrial fibrillation ablation outcomes with clinic ECG, monthly 24-h Holter ECG, and twice-daily telemonitoring ECG. Heart Vessels (2016) 0.78
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol (2016) 0.78
Left atrial appendage morphology in patients with suspected cardiogenic stroke without known atrial fibrillation. PLoS One (2015) 0.78
Atrial Fibrillation Predictors: Importance of the Electrocardiogram. Ann Noninvasive Electrocardiol (2015) 0.78
Stroke as the First Manifestation of Atrial Fibrillation. PLoS One (2016) 0.78
Screening For Atrial Fibrillation In The Community Using A Novel ECG Recorder. J Atr Fibrillation (2016) 0.77
Decade in review-stroke: Progress in acute ischaemic stroke treatment and prevention. Nat Rev Neurol (2015) 0.77
Epidemiology, diagnosis, and management of atrial fibrillation in women. Int J Womens Health (2015) 0.77
Atrial Fibrillation Identified During Echocardiography in a Patient with Recurrent Cardioembolic Events: A Case Report. Am J Case Rep (2016) 0.77
Detection of occult paroxysmal atrial fibrilation by implantable long-term electrocardiographic monitoring in cryptogenic stroke and transient ischemic attack population: a study protocol for prospective matched cohort study. BMC Cardiovasc Disord (2015) 0.76
Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials. Med Devices (Auckl) (2015) 0.76
Total atrial conduction time to predict occult atrial fibrillation after cryptogenic stroke. Clin Res Cardiol (2016) 0.76
Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia? Biomed Res Int (2015) 0.76
Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart (2015) 0.75
Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2015) 0.75
Atrial Fibrillation in Patients with Transient Ischemic Attack in Accordance with the Tissue-Based Definition. J Vasc Interv Neurol (2016) 0.75
Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention. F1000Res (2016) 0.75
Holter Monitoring and Loop Recorders: From Research to Clinical Practice. Arrhythm Electrophysiol Rev (2016) 0.75
Identification of Atrial Fibrillation by Quantitative Analyses of Fingertip Photoplethysmogram. Sci Rep (2017) 0.75
Comparison of Functional Outcome and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source (ESUS) vs. Cardioembolic Stroke Patients. PLoS One (2016) 0.75
Anticoagulation in Atrial Fibrillation - Current Concepts. Arrhythm Electrophysiol Rev (2015) 0.75
Stroke Imaging: Quantity, But is There Quality? Med Care (2016) 0.75
Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke. Neurology (2015) 0.75
Mechanisms and clinical significance of early recurrences of atrial arrhythmias after catheter ablation for atrial fibrillation. World J Cardiol (2016) 0.75
Detection of Atrial Fibrillation Among Patients With Stroke Due to Large or Small Vessel Disease: A Meta-Analysis. J Am Heart Assoc (2016) 0.75
Left atrial appendage exclusion for atrial fibrillation: does the protection from stroke prevail in the long-term? J Thorac Dis (2016) 0.75
Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis. Clin J Am Soc Nephrol (2016) 0.75
Obstructive Sleep Apnea as a Candidate Unifier in Atrial Fibrillation and Cryptogenic Stroke. Sleep (2015) 0.75
Left atrial septal pouch in cryptogenic stroke. Front Neurol (2015) 0.75
Optimization Of Stroke Prophylaxis Strategies In Nonvalvular AF -Drugs, Devices Or Both? J Atr Fibrillation (2015) 0.75
Diagnosis, prognosis, and management of cryptogenic stroke. F1000Res (2016) 0.75
HEart and BRain interfaces in Acute ischemic Stroke (HEBRAS) - rationale and design of a prospective oberservational cohort study. BMC Neurol (2015) 0.75
Opportunistic screening of atrial fibrillation by automatic blood pressure measurement in the community. BMJ Open (2016) 0.75
Silent Atrial Fibrillation: A Critical Review. J Atr Fibrillation (2014) 0.75
Cardiac diagnostic work-up for atrial fibrillation after transient ischaemic attacks in England and Wales: results from a cross-sectional survey. BMJ Open (2016) 0.75
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis (2016) 0.75
Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress. Front Physiol (2015) 0.75
The complexity of atrial fibrillation newly diagnosed after ischemic stroke and transient ischemic attack: advances and uncertainties. Curr Opin Neurol (2016) 0.75
Remote monitoring of cardiac implantable electronic devices (CIED). Trends Cardiovasc Med (2016) 0.75
Clinical and Economic Implications of AF Related Stroke. J Atr Fibrillation (2016) 0.75
Cryptogenic Stroke And Role Of Loop Recorder. J Atr Fibrillation (2014) 0.75
Optimization of Stroke Prophylaxis Strategies in Nonvalvular AF - Drugs, Devices or Both? J Atr Fibrillation (2016) 0.75
Differences in the Slope of the QT-RR Relation Based on 24-Hour Holter ECG Recordings between Cardioembolic and Atherosclerotic Stroke. Intern Med (2016) 0.75
Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long? Open Cardiovasc Med J (2016) 0.75
Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study. J Stroke Cerebrovasc Dis (2015) 0.75
Atrial fibrillation. Cryptogenic stroke--can we abandon this apologetic diagnosis? Nat Rev Cardiol (2014) 0.75
Atrial high-rate episodes and stroke prevention. Europace (2017) 0.75
Symptom/Rhythm Correlation With Patient Owned Device: Insights Into Practice And Challenges. J Atr Fibrillation (2016) 0.75
Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure: Results from the CARRYING ON for HF Pilot Study. JMIR Res Protoc (2016) 0.75
The burden of proof: The current state of atrial fibrillation prevention and treatment trials. Heart Rhythm (2017) 0.75
Percutaneous PFO closure for cryptogenic stroke in the setting of a systematic cardiac and neurological screening and a standardised follow-up protocol. Open Heart (2017) 0.75
Optimal Duration of Monitoring for Atrial Fibrillation in Cryptogenic Stroke: A Nonsystematic Review. Biomed Res Int (2016) 0.75
Electrocardiographic and Echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke. BMC Cardiovasc Disord (2016) 0.75
Association of Left Atrial Enlargement with Cortical Infarction in Subjects with Patent Foramen Ovale. J Stroke (2016) 0.75
Conjugate Eye Deviation on CT Associated With Worse Outcomes Despite IV Thrombolysis. Neurohospitalist (2016) 0.75
Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. J Am Heart Assoc (2016) 0.75
Novel Dielectric Coagulometer Identifies Hypercoagulability in Patients with a High CHADS2 Score without Atrial Fibrillation. PLoS One (2016) 0.75
Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy. Nat Rev Cardiol (2016) 0.75
Cardioembolic Stroke. Circ Res (2017) 0.75
Minimally Symptomatic Atrial Fibrillation Patients Derive Significant Symptom Relief Following Rate Control or Rhythm Control Therapy. J Clin Med Res (2015) 0.75
Clinical Reasoning: An 87-year-old woman with left-sided numbness. Neurology (2015) 0.75
Utility of Duranta, a wireless patch-type electrocardiographic monitoring system developed in Japan, in detecting covert atrial fibrillation in patients with cryptogenic stroke: A case report. Medicine (Baltimore) (2017) 0.75
Anticoagulation in elderly patients at high risk of atrial fibrillation without documented arrhythmias. J Geriatr Cardiol (2017) 0.75
[Implantable loop recorder in atrial fibrillation and after catheter ablation]. Herzschrittmacherther Elektrophysiol (2016) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Subclinical atrial fibrillation and the risk of stroke. N Engl J Med (2012) 11.11
Long-term consequences of kidney donation. N Engl J Med (2009) 10.17
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med (2015) 6.68
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 5.89
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Defibrillator implantation early after myocardial infarction. N Engl J Med (2009) 5.25
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet (2011) 5.17
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA (2005) 4.60
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol (2005) 4.40
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet (2003) 4.19
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol (2013) 3.76
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med (2013) 3.56
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA (2005) 3.54
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 3.48
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J (2005) 3.06
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke (2012) 3.02
Using dabigatran in patients with stroke: a practical guide for clinicians. Stroke (2011) 2.97
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation (2004) 2.81
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache (2010) 2.72
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J (2016) 2.70
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med (2012) 2.65
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. Heart Rhythm (2012) 2.65
Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm (2012) 2.60
Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation (2005) 2.56
Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49
Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache. Cephalalgia (2012) 2.46
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med (2011) 2.45
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace (2015) 2.35
Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain (2002) 2.15
Movement-related changes in synchronization in the human basal ganglia. Brain (2002) 2.15
Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia (2011) 2.07
The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol (2007) 2.05
Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke (2011) 2.04
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results. J Am Coll Cardiol (2008) 2.02
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol (2012) 1.99
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J (2008) 1.99
Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke (2009) 1.96
Existing motor state is favored at the expense of new movement during 13-35 Hz oscillatory synchrony in the human corticospinal system. J Neurosci (2005) 1.93
Predicting functional outcome and survival after acute ischemic stroke. J Neurol (2002) 1.92
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache (2006) 1.86
Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology (2014) 1.85
Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol (2013) 1.84
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J (2010) 1.76
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J Cardiovasc Electrophysiol (2007) 1.73
Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease. Exp Neurol (2008) 1.71
Heart rate variability in athletes. Sports Med (2003) 1.70
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke (2004) 1.69
Cluster headache: clinical features and therapeutic options. Dtsch Arztebl Int (2011) 1.69
Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul (2009) 1.68
Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.67
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial. Cephalalgia (2010) 1.67
Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol (2012) 1.67
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med (2008) 1.65
Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke (2007) 1.65
Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Radiology (2008) 1.64
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J (2007) 1.63
Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol (2011) 1.63
Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J (2012) 1.62
A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.59
Congestive heart failure in Latin America: the next epidemic. Am Heart J (2004) 1.58
Cryoballoon versus radiofrequency catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (2015) 1.55
Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care (2012) 1.55
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz (2009) 1.54
Lipopolysaccharide transport to the bacterial outer membrane in spheroplasts. J Biol Chem (2004) 1.53
Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional versus conservative treatment. Catheter Cardiovasc Interv (2012) 1.53
Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke (2010) 1.53